Esperion Therapeutics ESPR Prepaid inventory costs
Prepaid inventory costs at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept espr:PrepaidInventoryCosts.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's prepaid inventory costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's prepaid inventory costs?
- Esperion Therapeutics (ESPR) reported prepaid inventory costs of $54.93M in Q1 2026.
- How has Esperion Therapeutics's prepaid inventory costs changed year-over-year?
- Esperion Therapeutics's prepaid inventory costs increased by 201.6% year-over-year, from $18.21M to $54.93M.
- What does prepaid inventory costs mean?
- This reflects advance payments made to suppliers or manufacturers for the procurement of raw materials or finished drug products before they are received. It indicates the company's efforts to secure supply chain stability and manage production lead times. High levels may suggest proactive inventory management or potential supply chain constraints.